Ads
related to: sars-cov-2 antibody
Search results
The Global Blood Supply May Be Massively Contaminated
Mercola· 3 days agoIn a recent meta-analysis1,2 posted on preprints.org, Japanese researchers warn of potentially deadly risks to patients who receive blood from people who have taken mRNA COVID ...
Could current COVID vaccines protect against future outbreaks? New study offers hope
Orange County Register· 7 days agoA group of researchers had the future in mind when they asked if current COVID-19 vaccines and...
Explainer-What are the FLiRT COVID variants and are they more contagious? By Reuters
Investing.com· 6 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral...
St. Joseph News-Press· 22 hours agoSHELTON, CT / ACCESSWIRE / May 29, 2024 / NanoViricides, Inc. (NYSE American: NNVC ) (the...
From 'loser' to laureate: Nobel winner's advice to young scientists
Nature· 5 days ago“10 years ago, I was considered a loser,” she says. Advice she offers is to follow the work of your...
As COVID cases rise again, what do I need to know about the new FLiRT variants?
Medical Xpress· 5 days agoFrom the original Wuhan variant, to delta, to omicron, and several others in between, the virus has continued to evolve. New variants have driven repeated waves of infection and challenged doctors ...
NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.
The Kansas City Star· 7 days agoSHELTON, CT / ACCESSWIRE / May 23, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, reports that it ...
NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.
Morningstar· 7 days agoSHELTON, CT / ACCESSWIRE / May 23, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, reports that it ...